ライフサイエンスコーパス: non-communicable disease

1 untries (around 80% of DALYs attributable to non-communicable disease).

2 nd which has a growing prevalence of chronic non-communicable disease.

3 c, where three-quarters of mortality is from non-communicable disease.

4 Obesity is a common cause of non-communicable disease.

5 on could be a risk of development of chronic non communicable diseases.

6 h risk factors that include communicable and non-communicable diseases.

7 urvival and reduce disability, stunting, and non-communicable diseases.

8 with preventing and controlling the rise of non-communicable diseases.

9 contributor to adult obesity, diabetes, and non-communicable diseases.

10 als, and to address the emerging burden from non-communicable diseases.

11 al, neonatal, and nutritional causes towards non-communicable diseases.

12 risk of hormone-sensitive cancers and other non-communicable diseases.

13 s a major modifiable risk factor for chronic non-communicable diseases.

14 ld health services, but poorly in addressing non-communicable diseases.

15 se--eg, US$1029.10 for HIV/AIDS to $3.21 for non-communicable diseases.

16 tegrated into management of communicable and non-communicable diseases.

17 ly prevalent dual burden of communicable and non-communicable diseases.

18 e future rate of decline in communicable and non-communicable diseases.

19 such as obesity, diabetes, and other chronic non-communicable diseases.

20 on), with no discernible funding targeted to non-communicable diseases.

21 s part of a comprehensive strategy to reduce non-communicable diseases.

22 inflammation rooted in both communicable and non-communicable diseases.

23 e are no detailed assessments of late-onset, non-communicable diseases.

24 demiological transition from communicable to non-communicable diseases.

25 ths annually through its effects on multiple non-communicable diseases.

26 ary patterns are a global priority to reduce non-communicable diseases.

27 for beginning to confront the rising tide of non-communicable diseases.

28 l mortality, growth failure, and adult-onset non-communicable diseases.

29 ally in the context of the growing burden of non-communicable diseases.

30 , and help prevent such diet-related chronic non-communicable diseases.

31 s the richest 20% from a similar increase in non-communicable diseases (1.4 vs 5.3 years).

32 ction Plan for the Prevention and Control of Non-communicable Diseases 2013-2020, and in advancing th

33 and millions of adults at increased risk of non-communicable diseases after low birthweight.

34 eterminants are relevant to communicable and non-communicable disease alike.

35 ite the UN's political commitment to address non-communicable diseases and ensure universal access to

36 continued to shift away from communicable to non-communicable diseases and from premature death to ye

37 still persist in LICs--whereas the burden of non-communicable diseases and injuries has increased.

38 been learnt about prevention and control of non-communicable diseases and injuries, which is well su

39 is now confronting an increasing burden from non-communicable diseases and injuries.

40 o exceed the incremental gains in decreasing non-communicable diseases and injury burdens of high-inc

41 om communicable diseases narrowed over time, non-communicable diseases and injury burdens varied mark

42 trends in deaths caused by communicable and non-communicable diseases and injury.

43 significant global health burdens from both non-communicable diseases and micronutrient deficiencies

44 nearly 90% of expected disability is due to non-communicable diseases and most of the remainder to i

45 ations, while at the same time, diet-related non-communicable diseases and obesity have exponentially

46 Urgent action is now required to control non-communicable diseases and reduce fatal injuries in M

47 f the solution is city planning that reduces non-communicable diseases and road trauma while also man

48 This study shows the reversal of HIV/AIDS, non-communicable disease, and injury mortality trends in

49 eonatal, and nutritional disorders, 43% from non-communicable diseases, and 10% from injuries.

50 l health security, antimicrobial resistance, non-communicable diseases, and climate change-but also t

51 disorders increase risk for communicable and non-communicable diseases, and contribute to unintention

52 als (MDGs), addressing growing challenges of non-communicable diseases, and ensuring universal health

53 Mortality from tuberculosis, non-communicable diseases, and injuries decreased slight

54 maternal, perinatal, and nutritional causes, non-communicable diseases, and injury.

55 total budget to infectious diseases, 12% to non-communicable diseases, and less than 1% to injuries

56 rcinogenic agents is likely to prevent other non-communicable diseases, and the cause could be remove

57 neonatal, and nutritional disorders; second, non-communicable diseases; and third, injuries.

58 of adult mortality risks from infections and non-communicable diseases are a result of historical chi

59 Non-communicable diseases are increasingly common causes

60 the poor, which population interventions for non-communicable diseases are most applicable in differe

61 Non-communicable diseases are the leading global cause o

62 Non-communicable diseases are, however, already major pu

63 Since this transition, the prevention of non-communicable disease as well as communicable disease

64 association between socioeconomic status and non-communicable disease behavioural risk factors is wel

65 With an ageing global population comes major non-communicable disease burden, especially in low-incom

66 a were developed for key nutrients linked to non communicable diseases by an independent scientific c

67 5 initiative, a plan to cut mortality due to non-communicable diseases by 25% by 2025.

68 ing tobacco use and premature mortality from non-communicable diseases by a third by 2030.

69 ff ect of physical inactivity on these major non-communicable diseases by estimating how much disease

70 goal to reduce rates of death from chronic (non-communicable) disease by an additional 2% every year

71 nservative assumptions for each of the major non-communicable diseases, by country, to estimate how m

72 reach about half the mortality reduction in non-communicable diseases called for by the Sustainable

73 Among chronic non-communicable diseases, cardiometabolic diseases and

74 Burden of Disease Study 2010, the burden of non-communicable diseases (cardiovascular disease, cance

75 the world's richest 20%, on the other hand, non-communicable diseases caused 85% of death and disabi

76 plementation of an effective response to the non-communicable-disease crisis will need political comm

77 ing individuals towards risk of Diet Related Non-communicable Diseases (DR-NCDs).

78 and child health, other infectious diseases, non-communicable diseases, Ebola, and sector-wide approa

79 able Development Goals and the challenges of non-communicable diseases, economic inequality, and clim

80 DALYs from non-communicable diseases--especially ischaemic heart di

81 re prominently in the burgeoning epidemic of non-communicable diseases facing low- and middle-income

82 disorders accounted for 17.2 million deaths, non-communicable diseases for 28.1 million deaths and in

83 The burden of morbidity and mortality from non-communicable disease has risen worldwide and is acce

84 emiological evidence, the policy response to non-communicable diseases has been weak.

85 High rates of non-communicable diseases have also been described with

86 However, socioeconomic factors influencing non-communicable diseases have not been included in the

87 cable diseases in children towards those for non-communicable diseases in adults.

88 Asthma-one of the most common chronic, non-communicable diseases in children and adults-is char

89 re than 3 million deaths per year, most from non-communicable diseases in low-income and middle-incom

90 Global and regional estimates show that non-communicable diseases in old age are rising in impor

91 ting, care, and treatment, and management of non-communicable diseases in the poorest populations.

92 by 2008, with 446 annual excess deaths from non-communicable diseases in the UK (280 for young peopl

93 Mortality from non-communicable diseases in the UK fell from being roug

94 ighlight the need to focus more attention on non-communicable diseases in this population and balance

95 cates early life factors in the aetiology of non-communicable diseases, including asthma/wheezing dis

96 Non-communicable diseases, including cancer, are overtak

97 The most common non-communicable diseases, including ischaemic heart dis

98 cularly for infant deaths and mortality from non-communicable diseases, including neuropsychiatric di

99 ealthy eating guidelines that aim to prevent non-communicable diseases (increase fruits, vegetables,

100 Deaths from non-communicable diseases increased over time in both se

101 As the prevalence of injuries and non-communicable diseases increases, the provision of ef

102 e probability of a man or woman dying from a non-communicable disease is higher in sub-Saharan Africa

103 countries in the Gulf region, the burden of non-communicable diseases is a major threat, primarily d

104 atus and increasing burden of mortality from non-communicable diseases is likely to become prominent.

105 egulated at the international level, such as non-communicable diseases, mental health, and injuries.

106 evelopment Goal (SDG) 3.4-reducing premature non-communicable disease mortality by a third by 2030-sh

107 We projected that non-communicable disease mortality will increase from 28

108 cable diseases (n=131), nutrition (n=77), to non-communicable diseases (n=8), and water, sanitation,

109 lar disease contributes substantially to the non-communicable disease (NCD) burden in low-income and

110 by age and gender, by communicable (CD) and non-communicable disease (NCD) causes.

111 regression was used to analyse all-cause and non-communicable disease (NCD) mortality between 2006 an

112 Heightened risk of non-communicable diseases (NCD) in children exposed to S

113 low-income countries, care for patients with non-communicable diseases (NCDs) and mental health condi

114 educe premature mortality from the four main non-communicable diseases (NCDs) by 25% from 2010 levels

115 The approaches to prevention and control of non-communicable diseases (NCDs) have been elaborated in

116 The burden of non-communicable diseases (NCDs) is disproportionately c

117 Non-communicable diseases (NCDs) such as cardiovascular

118 communities have a higher risk of dying from non-communicable diseases (NCDs) than do more advantaged

119 re experiencing an increase in the burden of non-communicable diseases (NCDs), including cancer.

120 ges of 30 years and 70 years) from four main non-communicable diseases (NCDs)--cardiovascular disease

121 provide an untapped opportunity to identify non-communicable diseases (NCDs).

122 people will increasingly develop age-related non-communicable diseases (NCDs).

123 ria deaths; a third of premature deaths from non-communicable diseases (NCDs); and a third of those f

124 The threat of non-communicable diseases ("NCDs") is increasingly becom

125 e fraction: malaria 8.0% and syphilis 7.7%), non-communicable diseases, nutrition and lifestyle facto

126 n, the HIV epidemic, and increasing rates of non-communicable diseases, people in sub-Saharan Africa

127 Cancer is one of the major non-communicable diseases posing a threat to world healt

128 Growing political recognition of non-communicable diseases provides a favourable politica

129 The rise in diabetes and other non-communicable diseases puts a heavy toll on health sy

130 years, due to population ageing, changes in non-communicable disease rates, and increasing air pollu

131 roups and regions, although communicable and non-communicable diseases remained the main causes of de

132 ers of diets associated with lower or higher non-communicable disease risk on the basis of multivaria

133 Deaths from non-communicable diseases rose by just under 8 million b

134 ated focus areas (other infectious diseases, non-communicable diseases, sector-wide approaches, and o

135 The communicable disease and non-communicable disease sectors need to move beyond con

136 ement in the global monitoring framework for non-communicable diseases should promote accountability

137 Treatment of non-communicable diseases such as cancer in refugees is

138 y adverse health conditions, including major non-communicable diseases such as coronary heart disease

139 ce of many pathologies, particularly chronic non-communicable diseases such as obesity and diabetes.

140 Worldwide, communicable and non-communicable diseases tend to segregate geographical

141 es, coronary heart disease and other chronic non-communicable diseases that lower global life expecta

142 in infancy and childhood as well as chronic, non-communicable diseases that may manifest at any point

143 ical transitions from diseases of poverty to non-communicable diseases, the burden of disease and hea

144 er an accelerated rate of overall decline in non-communicable diseases, the poor-rich gap would widen

145 ibute to worldwide epidemics of injuries and non-communicable diseases through traffic exposure, nois

146 The burden of non-communicable diseases, to which cancer contributes g

147 sulin treatment, blood glucose level, having non-communicable diseases were significantly associated

148 Most increases in DALYs, especially from non-communicable diseases, were due to population growth

149 untries (around 50% of DALYs attributable to non-communicable disease), whereas China more closely re

150 ed therapies include commonly used drugs for non-communicable diseases with good safety profiles, imm

151 riority on addressing the high prevalence of non-communicable diseases, with variations in policies b

152 pheral artery disease is a prevalent chronic non-communicable disease without obvious symptoms.